David Felsted, DO
Ophthalmology · Augusta, GANPI 1467814830
Payments from drug & device makers
Across 67 payments — averaging $68.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$1K
- Carl Zeiss Meditec, Inc.$1K
- Alcon$1K
- Alcon Research LLC$350
- Sun Pharmaceutical Industries Inc.$169
- Glaukos Corporation$163
- plus $773 from 12 others
What the payments were for
- Consulting fees$2,60057%
- Food & beverage$1,97543%
- Education$251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 4 | $1,101 |
| Carl Zeiss Meditec, Inc. | 2 | $1,043 |
| Alcon | 23 | $1,001 |
| Alcon Research LLC | 1 | $350 |
| Sun Pharmaceutical Industries Inc. | 2 | $169 |
| Glaukos Corporation | 5 | $163 |
| Sight Sciences, Inc. | 5 | $163 |
| Shire North American Group Inc | 1 | $122 |
| Ivantis, Inc | 4 | $115 |
| Amgen(2 entities) | 4 | $73 |
| Rayner Intraocular Lenses Limited | 4 | $73 |
| Ocular Therapeutix, Inc. | 3 | $64 |
| AbbVie(2 entities) | 3 | $63 |
| Dompe US, Inc. | 2 | $37 |
| Rxsight Inc | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Biotissue Holdings Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Simplicity$1,027
- ARTEVO 800$1,000
- IOLMaster 700$1,000
- VERACITY SURGICAL$1,000
- AcrySof$469
- Tecnis IOL$382
- CEQUA$149
- BROMSITE$149
- VERITAS Vision System$127
- XIIDRA$122
- OMNI(R) SURGICAL SYSTEM (US)$108
How this compares
$4,600 in reported general payments places this provider in the 65th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 620 | $10,774 |
| Prednisolone Acetate | 124 | $4,654 |
| Travoprost | 11 | $1,753 |
| Latanoprost | 95 | $1,122 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $726 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 30 | $363 |
| Timolol Maleate | 23 | $339 |
| Brimonidine Tartrate | 11 | $309 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Augusta
- Dennis MarcusAugusta$9.2M
- Robert StoltzMarietta$3.9M
- Eugene McLaurinSavannah$3.3M
- Clayton BlehmGainesville$1.7M
- Lakshmana KooragayalaMarietta$1.4M
- Douglas DayAtlanta$1.1M
- Jennifer KimMorrow$989K
- Thomas AabergAtlanta$959K
- Gagan SawhneyAtlanta$874K
- Lawrence WoodardAtlanta$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.